{"entity":{"type":"insider","cik":"0001455150","url":"/insider/0001455150","json_url":"/insider/0001455150.json","name":"Parsons C. Lowell","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":16,"n_filings":8,"first":"2009-03-02","last":"2009-10-13","span_basis":"filed_date"},"name_variants":[{"name":"Parsons C. Lowell","source":"filing","n_filings":8,"first_seen":"2009-03-02","last_seen":"2009-10-13"}],"transactions":[{"id":5584270,"accession":"0001013762-09-001829","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001013762-09-001829","line_url":"/filing/0001013762-09-001829#line-4","is_derivative":false,"issuer_cik":"0000932352","issuer_name":"Urigen Pharmaceuticals, Inc.","issuer_ticker":"UGRP.OB","issuer_name_source":null,"issuer_url":"/issuer/0000932352","owner_cik":"0001455150","owner_name":"Parsons C. Lowell","owner_display_name":"Parsons C. Lowell","owner_url":"/insider/0001455150","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, $.001 Par Value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":0.065,"price_display":"0.06","price_state":"stated","total_value":650.0,"total_display":"650.00","total_whole":"650","shares_owned_after":1968693.0,"shares_owned_after_display":"1,968,693","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-10-05","filed_date":"2009-10-13","scope":"insider"},{"id":5584269,"accession":"0001013762-09-001829","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001013762-09-001829","line_url":"/filing/0001013762-09-001829#line-3","is_derivative":false,"issuer_cik":"0000932352","issuer_name":"Urigen Pharmaceuticals, Inc.","issuer_ticker":"UGRP.OB","issuer_name_source":null,"issuer_url":"/issuer/0000932352","owner_cik":"0001455150","owner_name":"Parsons C. Lowell","owner_display_name":"Parsons C. Lowell","owner_url":"/insider/0001455150","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, $.001 Par Value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":13000.0,"shares_display":"13,000","price_per_share":0.065,"price_display":"0.06","price_state":"stated","total_value":845.0,"total_display":"845.00","total_whole":"845","shares_owned_after":1958693.0,"shares_owned_after_display":"1,958,693","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-10-02","filed_date":"2009-10-13","scope":"insider"},{"id":5584268,"accession":"0001013762-09-001829","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001013762-09-001829","line_url":"/filing/0001013762-09-001829","is_derivative":false,"issuer_cik":"0000932352","issuer_name":"Urigen Pharmaceuticals, Inc.","issuer_ticker":"UGRP.OB","issuer_name_source":null,"issuer_url":"/issuer/0000932352","owner_cik":"0001455150","owner_name":"Parsons C. Lowell","owner_display_name":"Parsons C. Lowell","owner_url":"/insider/0001455150","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, $.001 Par Value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":30000.0,"shares_display":"30,000","price_per_share":0.06333333333333334,"price_display":"0.06","price_state":"stated","total_value":1900.0,"total_display":"1,900.00","total_whole":"1,900","shares_owned_after":1945693.0,"shares_owned_after_display":"1,945,693","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-10-01","filed_date":"2009-10-13","scope":"insider","n_lines":2},{"id":5893961,"accession":"0001013762-09-001387","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001013762-09-001387","line_url":"/filing/0001013762-09-001387#line-1","is_derivative":false,"issuer_cik":"0000932352","issuer_name":"Urigen Pharmaceuticals, Inc.","issuer_ticker":"UGRP.OB","issuer_name_source":null,"issuer_url":"/issuer/0000932352","owner_cik":"0001455150","owner_name":"Parsons C. Lowell","owner_display_name":"Parsons C. Lowell","owner_url":"/insider/0001455150","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, $.001 Par Value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":0.07,"price_display":"0.07","price_state":"stated","total_value":1400.0,"total_display":"1,400.00","total_whole":"1,400","shares_owned_after":1925693.0,"shares_owned_after_display":"1,925,693","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-07-28","filed_date":"2009-08-05","scope":"insider"},{"id":6035444,"accession":"0001013762-09-001053","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001013762-09-001053","line_url":"/filing/0001013762-09-001053#line-1","is_derivative":false,"issuer_cik":"0000932352","issuer_name":"Urigen Pharmaceuticals, Inc.","issuer_ticker":"UGRP.OB","issuer_name_source":null,"issuer_url":"/issuer/0000932352","owner_cik":"0001455150","owner_name":"Parsons C. Lowell","owner_display_name":"Parsons C. Lowell","owner_url":"/insider/0001455150","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, $.001 Par Value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7500.0,"shares_display":"7,500","price_per_share":0.09,"price_display":"0.09","price_state":"stated","total_value":675.0,"total_display":"675.00","total_whole":"675","shares_owned_after":1905693.0,"shares_owned_after_display":"1,905,693","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-06-01","filed_date":"2009-06-05","scope":"insider"},{"id":5660059,"accession":"0001013762-09-000995","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001013762-09-000995","line_url":"/filing/0001013762-09-000995#line-2","is_derivative":false,"issuer_cik":"0000932352","issuer_name":"Urigen Pharmaceuticals, Inc.","issuer_ticker":"UGRP.OB","issuer_name_source":null,"issuer_url":"/issuer/0000932352","owner_cik":"0001455150","owner_name":"Parsons C. Lowell","owner_display_name":"Parsons C. Lowell","owner_url":"/insider/0001455150","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, $.001 Par Value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7500.0,"shares_display":"7,500","price_per_share":0.085,"price_display":"0.08","price_state":"stated","total_value":637.5,"total_display":"637.50","total_whole":"638","shares_owned_after":1898193.0,"shares_owned_after_display":"1,898,193","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-05-26","filed_date":"2009-05-29","scope":"insider"},{"id":5660058,"accession":"0001013762-09-000995","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001013762-09-000995","line_url":"/filing/0001013762-09-000995#line-1","is_derivative":false,"issuer_cik":"0000932352","issuer_name":"Urigen Pharmaceuticals, Inc.","issuer_ticker":"UGRP.OB","issuer_name_source":null,"issuer_url":"/issuer/0000932352","owner_cik":"0001455150","owner_name":"Parsons C. Lowell","owner_display_name":"Parsons C. Lowell","owner_url":"/insider/0001455150","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, $.001 Par Value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7500.0,"shares_display":"7,500","price_per_share":0.08,"price_display":"0.08","price_state":"stated","total_value":600.0,"total_display":"600.00","total_whole":"600","shares_owned_after":1890693.0,"shares_owned_after_display":"1,890,693","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-05-22","filed_date":"2009-05-29","scope":"insider"},{"id":5775272,"accession":"0001013762-09-000507","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001013762-09-000507","line_url":"/filing/0001013762-09-000507#line-1","is_derivative":false,"issuer_cik":"0000932352","issuer_name":"Urigen Pharmaceuticals, Inc.","issuer_ticker":"UGRP.OB","issuer_name_source":null,"issuer_url":"/issuer/0000932352","owner_cik":"0001455150","owner_name":"Parsons C. Lowell","owner_display_name":"Parsons C. Lowell","owner_url":"/insider/0001455150","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, $.001 Par Value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2500.0,"shares_display":"2,500","price_per_share":0.9,"price_display":"0.90","price_state":"stated","total_value":2250.0,"total_display":"2,250.00","total_whole":"2,250","shares_owned_after":1883193.0,"shares_owned_after_display":"1,883,193","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-03-17","filed_date":"2009-03-26","scope":"insider"},{"id":5853512,"accession":"0001013762-09-000443","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001013762-09-000443","line_url":"/filing/0001013762-09-000443#line-2","is_derivative":false,"issuer_cik":"0000932352","issuer_name":"Urigen Pharmaceuticals, Inc.","issuer_ticker":"UGRP.OB","issuer_name_source":null,"issuer_url":"/issuer/0000932352","owner_cik":"0001455150","owner_name":"Parsons C. Lowell","owner_display_name":"Parsons C. Lowell","owner_url":"/insider/0001455150","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, $.001 Par Value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3000.0,"shares_display":"3,000","price_per_share":0.8,"price_display":"0.80","price_state":"stated","total_value":2400.0,"total_display":"2,400.00","total_whole":"2,400","shares_owned_after":1880693.0,"shares_owned_after_display":"1,880,693","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-03-16","filed_date":"2009-03-17","scope":"insider"},{"id":5853510,"accession":"0001013762-09-000443","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001013762-09-000443","line_url":"/filing/0001013762-09-000443#line-1","is_derivative":false,"issuer_cik":"0000932352","issuer_name":"Urigen Pharmaceuticals, Inc.","issuer_ticker":"UGRP.OB","issuer_name_source":null,"issuer_url":"/issuer/0000932352","owner_cik":"0001455150","owner_name":"Parsons C. Lowell","owner_display_name":"Parsons C. Lowell","owner_url":"/insider/0001455150","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, $.001 Par Value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7500.0,"shares_display":"7,500","price_per_share":0.9,"price_display":"0.90","price_state":"stated","total_value":6750.0,"total_display":"6,750.00","total_whole":"6,750","shares_owned_after":1877693.0,"shares_owned_after_display":"1,877,693","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-03-13","filed_date":"2009-03-17","scope":"insider"},{"id":5833890,"accession":"0001013762-09-000383","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001013762-09-000383","line_url":"/filing/0001013762-09-000383#line-2","is_derivative":false,"issuer_cik":"0000932352","issuer_name":"Urigen Pharmaceuticals, Inc.","issuer_ticker":"UGRP.OB","issuer_name_source":null,"issuer_url":"/issuer/0000932352","owner_cik":"0001455150","owner_name":"Parsons C. Lowell","owner_display_name":"Parsons C. Lowell","owner_url":"/insider/0001455150","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, $.001 Par Value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6000.0,"shares_display":"6,000","price_per_share":0.08,"price_display":"0.08","price_state":"stated","total_value":480.0,"total_display":"480.00","total_whole":"480","shares_owned_after":1870193.0,"shares_owned_after_display":"1,870,193","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-03-06","filed_date":"2009-03-09","scope":"insider"},{"id":5833888,"accession":"0001013762-09-000383","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001013762-09-000383","line_url":"/filing/0001013762-09-000383#line-1","is_derivative":false,"issuer_cik":"0000932352","issuer_name":"Urigen Pharmaceuticals, Inc.","issuer_ticker":"UGRP.OB","issuer_name_source":null,"issuer_url":"/issuer/0000932352","owner_cik":"0001455150","owner_name":"Parsons C. Lowell","owner_display_name":"Parsons C. Lowell","owner_url":"/insider/0001455150","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, $.001 Par Value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1500.0,"shares_display":"1,500","price_per_share":0.1,"price_display":"0.10","price_state":"stated","total_value":150.0,"total_display":"150.00","total_whole":"150","shares_owned_after":1864193.0,"shares_owned_after_display":"1,864,193","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-03-03","filed_date":"2009-03-09","scope":"insider"},{"id":5870619,"accession":"0001013762-09-000334","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001013762-09-000334","line_url":"/filing/0001013762-09-000334#line-3","is_derivative":false,"issuer_cik":"0000932352","issuer_name":"Urigen Pharmaceuticals, Inc.","issuer_ticker":"UGRP.OB","issuer_name_source":null,"issuer_url":"/issuer/0000932352","owner_cik":"0001455150","owner_name":"Parsons C. Lowell","owner_display_name":"Parsons C. Lowell","owner_url":"/insider/0001455150","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock $.001 Par Value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":0.1,"price_display":"0.10","price_state":"stated","total_value":500.0,"total_display":"500.00","total_whole":"500","shares_owned_after":1862693.0,"shares_owned_after_display":"1,862,693","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-02-27","filed_date":"2009-03-02","scope":"insider"},{"id":5870616,"accession":"0001013762-09-000334","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001013762-09-000334","line_url":"/filing/0001013762-09-000334#line-2","is_derivative":false,"issuer_cik":"0000932352","issuer_name":"Urigen Pharmaceuticals, Inc.","issuer_ticker":"UGRP.OB","issuer_name_source":null,"issuer_url":"/issuer/0000932352","owner_cik":"0001455150","owner_name":"Parsons C. Lowell","owner_display_name":"Parsons C. Lowell","owner_url":"/insider/0001455150","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock $.001 Par Value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":0.1,"price_display":"0.10","price_state":"stated","total_value":1000.0,"total_display":"1,000.00","total_whole":"1,000","shares_owned_after":1857693.0,"shares_owned_after_display":"1,857,693","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-02-26","filed_date":"2009-03-02","scope":"insider"},{"id":5870613,"accession":"0001013762-09-000334","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001013762-09-000334","line_url":"/filing/0001013762-09-000334#line-1","is_derivative":false,"issuer_cik":"0000932352","issuer_name":"Urigen Pharmaceuticals, Inc.","issuer_ticker":"UGRP.OB","issuer_name_source":null,"issuer_url":"/issuer/0000932352","owner_cik":"0001455150","owner_name":"Parsons C. Lowell","owner_display_name":"Parsons C. Lowell","owner_url":"/insider/0001455150","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock $.001 Par Value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":0.1,"price_display":"0.10","price_state":"stated","total_value":500.0,"total_display":"500.00","total_whole":"500","shares_owned_after":1847693.0,"shares_owned_after_display":"1,847,693","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-02-25","filed_date":"2009-03-02","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":16,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":16,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":16},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000932352","name":"Urigen Pharmaceuticals, Inc.","url":"/issuer/0000932352","role":"Director","n_filings":8,"first_seen":"2009-03-02","last_seen":"2009-10-13"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001455150","retrieved_at":"2026-08-27T00:39:00+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}